Quick Answer
FENNEC PHARMACEUTICALS INC. reported Diluted EPS of $0.34 per share (loss) for fiscal year 2025.
FENNEC PHARMACEUTICALS INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.34 | -1600.0% |
| 2024 | -$0.02 | +96.7% |
| 2023 | -$0.60 | +33.3% |
| 2022 | -$0.90 | -34.3% |
| 2021 | -$0.67 | +11.8% |
| 2020 | -$0.76 | -245.5% |
| 2014 | -$0.22 | -229.4% |
| 2013 | $0.17 | +181.0% |
| 2012 | -$0.21 | -210.5% |
| 2011 | $0.19 | +138.8% |
| 2010 | -$0.49 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.02 | +90.5% | +81.8% |
| June 30, 2025 | -$0.11 | +45.0% | -175.0% |
| March 31, 2025 | -$0.04 | -109.8% | +81.0% |
| September 30, 2024 | -$0.21 | -200.0% | -5.0% |
| June 30, 2024 | -$0.20 | +4.8% | -148.8% |
| March 31, 2024 | $0.41 | +278.3% | +685.7% |
| September 30, 2023 | -$0.07 | +77.4% | +66.7% |
| June 30, 2023 | -$0.21 | -10.5% | +8.7% |
- FENNEC PHARMACEUTICALS INC. showed a decrease of -1600.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2010–2025 period, FENNEC PHARMACEUTICALS INC.’s diluted eps has grown by 30.6% (from $0.49 per share (loss) to $0.34 per share (loss)).
- The most recent figure is from FENNEC PHARMACEUTICALS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: